Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Javier Munoz

18PUBLICATIONS

99CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursTraditional Chinese medicine and treatmentsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (18)

Sort by Publication Date:

|Apr 25, 2026

Mantle cell lymphoma outcomes following sequential first-line bendamustine-rituximab and second-line Bruton's tyrosine kinase inhibitor therapy.

|Feb 27, 2026

At the Crossroads of Lineage: Secondary Malignancies After CAR-Based Immunotherapy.

Logan Lorentzen, Mazie Tsang, Talal Hilal

|Oct 16, 2025

Eliminating REMS for CAR T-Cell Therapies: An Opportunity to Improve Access.

Angel Luis Orosco-Ttamina, Cecilia Arana Yi, Mazie Tsang

|Feb 13, 2025

Allogeneic Chimeric Antigen Receptor T-Cell Products Cemacabtagene Ansegedleucel/ALLO-501 in Relapsed/Refractory Large B-Cell Lymphoma: Phase I Experience From the ALPHA2/ALPHA Clinical Studies.

Frederick L Locke, Javier L Munoz, Michael T Tees

|Feb 12, 2025

Three-year follow-up analysis of first-line axicabtagene ciloleucel for high-risk large B-cell lymphoma: the ZUMA-12 study.

Julio C Chavez, Michael Dickinson, Javier Munoz

|Feb 08, 2025

Results from an open-label phase 2a study of cerdulatinib, a dual spleen tyrosine kinase/janus kinase inhibitor, in relapsed/refractory peripheral T-cell lymphoma.

Steven M Horwitz, Tatyana A Feldman, Jing Christine Ye

Pageof 3

Frequent Collaborators

6 joint publications

Sattva S Neelapu

6 joint publications

David Miklos

6 joint publications

Olalekan Oluwole

5 joint publications

Andre H Goy

4 joint publications

Frederick L Locke

4 joint publications

Abhinav Deol

3 joint publications

Yucai Wang

3 joint publications

Saurabh Dahiya

3 joint publications

Joseph P Mcguirk

3 joint publications

Julie M Vose

Frequent Collaborators

6 joint publications

Sattva S Neelapu

6 joint publications

David Miklos

6 joint publications

Olalekan Oluwole

5 joint publications

Andre H Goy

Top Related Videos

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on : Mar 30, 2018

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on : Feb 21, 2025

Generation and Functional Verification of Hypoxia-Sensitive Chimeric Antigen Receptor-T Cells

Generation and Functional Verification of Hypoxia-Sensitive Chimeric Antigen Receptor-T Cells

Published on : Jun 14, 2024

See more related videos

Top Related Videos

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on : Mar 30, 2018

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on : Feb 21, 2025

Generation and Functional Verification of Hypoxia-Sensitive Chimeric Antigen Receptor-T Cells

Generation and Functional Verification of Hypoxia-Sensitive Chimeric Antigen Receptor-T Cells

Published on : Jun 14, 2024

See more related videos